|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4780987A
(en)
|
1983-10-25 |
1988-11-01 |
Plant Genetics, Inc. |
Method for the preparation of hydrated, pregerminated seeds in gel capsules
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
JP2733849B2
(ja)
|
1987-10-12 |
1998-03-30 |
ボロディー，ソーマス・ユリウス |
胃腸障害治療のための改良された方法
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
DE68928665T2
(de)
|
1988-08-02 |
1998-11-12 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
KR950703640A
(ko)
|
1992-10-09 |
1995-09-20 |
가일 케이,나우톤. |
간 보존 세포(liver reserve cells)
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
US5851545A
(en)
|
1995-08-25 |
1998-12-22 |
Sandoz Ltd. |
Insecticidal matrix and process for preparation thereof
|
|
EP0952773B1
(en)
|
1995-09-15 |
2005-11-23 |
Dale N. Gerding |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
FI106042B
(fi)
|
1999-07-12 |
2000-11-15 |
Tekno Forest Oy |
Vedenpuhdistusmenetelmä, siihen soveltuvia bakteereja ja niiden käyttö
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US6613549B2
(en)
|
2000-02-10 |
2003-09-02 |
Urex Biotech, Inc. |
Probiotic therapy for newborns
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
CA2430292A1
(en)
|
2000-11-30 |
2002-06-06 |
The Bio Balance Corp. |
Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
|
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
|
EP1527164A4
(en)
|
2001-05-04 |
2006-02-01 |
Univ Florida |
CLONING AND SEQUENCING OF PYRUVATE CARBOXYLASE (PDC) GENES FROM BACTERIA AND USES THEREOF
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
US20050180962A1
(en)
|
2003-01-30 |
2005-08-18 |
Eyal Raz |
Inactivated probiotic bacteria and methods of use thereof
|
|
WO2004101770A1
(en)
|
2003-03-13 |
2004-11-25 |
Universite De Moncton (Bureau De Soutien A L'innovation) |
Antioxidant producing bacterium and uses thereof
|
|
CA2522957C
(en)
|
2003-04-23 |
2013-10-22 |
Medarex, Inc. |
Compositions and methods for the therapy of inflammatory bowel disease
|
|
EP1473370A3
(en)
|
2003-04-24 |
2005-03-09 |
BioMerieux, Inc. |
Genus, group, species and/or strain specific 16S rDNA Sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
AU2004267383A1
(en)
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Bacterial strains, compositions including same and probiotic use thereof
|
|
AU2004265511A1
(en)
|
2003-08-18 |
2005-02-24 |
The Bio Balance Corporation |
A stable liquid probiotic composition, preparation and applications thereof
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
CN1913787B
(zh)
|
2004-02-03 |
2014-11-26 |
增值研究合伙有限公司 |
在动物中促进生长的活体细菌的应用
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
US7521201B2
(en)
|
2004-11-01 |
2009-04-21 |
Strategic Diagnostics Inc. |
Bacteriophages as selective agents
|
|
EP1815016B1
(en)
|
2004-11-01 |
2012-06-27 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7627437B2
(en)
|
2005-01-14 |
2009-12-01 |
Idaho Research Foundation |
Categorization of microbial communities
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
MX2007011631A
(es)
|
2005-03-25 |
2007-11-22 |
Univ Gent |
Desmetilacion enzimatica de favonoides.
|
|
JP4938006B2
(ja)
|
2005-05-31 |
2012-05-23 |
ザ・アイムス・カンパニー |
ネコ科動物プロバイオティク・ビフィドバクテリア
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
DK1931363T3
(en)
|
2005-09-28 |
2016-02-22 |
Nordisk Rebalance As |
Treatment of IBD using both probiotic bacteria and fermented cereal as behandlingseffektorer
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
EP2035544A2
(en)
|
2006-05-18 |
2009-03-18 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
US20090324638A1
(en)
|
2006-06-12 |
2009-12-31 |
Biopeptides Corp. |
Live bacterial vaccine
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
JP2009541298A
(ja)
|
2006-06-20 |
2009-11-26 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
胃腸障害を処置するための電子カプセル
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
US8518873B2
(en)
|
2007-09-12 |
2013-08-27 |
The Medicines Company |
Method of inhibiting clostridium difficile by administration of oritavancin
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
RU2010144789A
(ru)
|
2008-04-01 |
2012-05-10 |
Метаметрикс Клиникал Лэборетери (Us) |
Процесс и способ мониторинга желудочно-кишечной микрофлоры
|
|
CN101264107A
(zh)
|
2008-05-09 |
2008-09-17 |
东北制药集团公司沈阳第一制药厂 |
地衣芽孢杆菌药物组合物及其制剂
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
EP2313773A1
(en)
|
2008-07-15 |
2011-04-27 |
Metanomics Health GmbH |
Means and methods diagnosing gastric bypass and conditions related thereto
|
|
CN102131928A
(zh)
|
2008-08-26 |
2011-07-20 |
奥林巴斯株式会社 |
粪便试样的调制方法、粪便试样调制用溶液、及粪便采集用试剂盒
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
|
EP2367839A4
(en)
|
2008-11-03 |
2012-07-04 |
Univ Tufts |
METHOD AND COMPOSITIONS FOR INHIBITING CLOSTRIDIUM DIFFICILE SPORTS NUTRITION AND GROWTH
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
CN102985550A
(zh)
|
2009-04-20 |
2013-03-20 |
奎特罗斯公司 |
用于生物质发酵的组合物和方法
|
|
US20120128633A1
(en)
|
2009-04-30 |
2012-05-24 |
Campagnie Gervaise Donone |
Use of collinsella aerofaciens for reducing bloating
|
|
DK2419114T4
(da)
|
2009-05-01 |
2019-05-27 |
Uas Laboratories Llc |
Bakteriesammensætninger til profylakse og behandling af degenerative sygdomme
|
|
JP2010280640A
(ja)
|
2009-06-08 |
2010-12-16 |
Kirin Holdings Co Ltd |
穀類植物種子由来の不溶性食物繊維を含有する大腸癌予防用物質
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
WO2011046614A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
US20120165215A1
(en)
|
2009-06-26 |
2012-06-28 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
MX2012002039A
(es)
|
2009-08-18 |
2012-04-11 |
Nestec Sa |
Una composicion nutricional que comprende cepas de lactococcus y que reduce los sintomas de la alergia, especialmente en infantes y en niños.
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
US20120149584A1
(en)
|
2009-08-21 |
2012-06-14 |
Bernat Olle |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
ES2660008T3
(es)
|
2009-09-23 |
2018-03-20 |
Thomas Julius Borody |
Terapia para infecciones entéricas crónicas
|
|
CA2776420A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
US20120276149A1
(en)
|
2009-10-15 |
2012-11-01 |
Dan Littman |
Methods for modulating bacterial infection
|
|
DK2498626T3
(en)
|
2009-11-12 |
2015-07-13 |
Nestec Sa |
FOOD COMPOSITION TO PROMOTE GAS MICROFLORAL BALANCE AND HEALTH
|
|
MX348611B
(es)
|
2009-12-31 |
2017-06-21 |
Milton Trachtman Ira |
Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana.
|
|
EP4663746A3
(en)
|
2010-02-01 |
2026-04-15 |
Ferring Microbiome Inc. |
Bacteriotherapy for clostridium difficile colitis
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
US20130230498A1
(en)
|
2010-02-16 |
2013-09-05 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
CA2791464A1
(en)
|
2010-03-01 |
2011-09-09 |
Institut National De La Recherche Agronomique |
Method of diagnosis of obesity
|
|
CN102939391A
(zh)
|
2010-03-01 |
2013-02-20 |
国家农艺研究院 |
炎症性肠病的诊断方法
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
US10487332B2
(en)
|
2010-07-06 |
2019-11-26 |
Glaxosmithkline Biologicals Sa |
Immunisation of large mammals with low doses of RNA
|
|
BR112013001107B1
(pt)
|
2010-07-16 |
2022-01-25 |
The Board Of Trustees Of The University Of Arkansas |
Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais
|
|
FI20105825A7
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
US8980279B2
(en)
|
2010-07-26 |
2015-03-17 |
Qu Biologics |
Personalized site-specific immunomodulation
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
US20130224164A1
(en)
|
2010-09-10 |
2013-08-29 |
Viropharma Incorporated |
Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use
|
|
EP2646567A4
(en)
|
2010-10-04 |
2014-03-26 |
British Columbia Cancer Agency |
DETECTION OF FUSOBACTERIUM IN A GASTROINTESTINAL SAMPLE FOR THE DIAGNOSIS OF GASTROINTESTINAL CARCINOMA
|
|
EP2662078A1
(en)
|
2010-11-10 |
2013-11-13 |
National Jewish Health |
Methods to Treat Allergic Conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
CN103491969A
(zh)
|
2011-02-09 |
2014-01-01 |
拉维沃公司 |
恢复和重建肠道微生物群的合生素组合物
|
|
US8511540B2
(en)
|
2011-02-18 |
2013-08-20 |
Echostar Technologies L.L.C. |
Matrix code for use in verification of data card swap
|
|
TW201247875A
(en)
|
2011-02-25 |
2012-12-01 |
Tricorder Diagnostics Llc |
Microbial signatures as indicators of radiation exposure
|
|
BR112013022927A2
(pt)
|
2011-03-09 |
2016-12-06 |
Univ Minnesota |
composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
US20120278201A1
(en)
|
2011-04-26 |
2012-11-01 |
Dwolla Corp. |
Location transaction processing system
|
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
US20140348811A1
(en)
|
2011-07-27 |
2014-11-27 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
CA2851602C
(en)
|
2011-08-30 |
2020-07-14 |
Academisch Medisch Centrum |
Method for preventing and/or treating insulin resistance
|
|
EP2756071B1
(en)
|
2011-09-14 |
2017-12-20 |
University Of Guelph |
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
US20130115232A1
(en)
|
2011-10-03 |
2013-05-09 |
Fred Hutchinson Cancer Research Center |
Methods for detecting graft-versus-host disease
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
DK2750682T3
(en)
|
2011-10-11 |
2016-08-22 |
Achim Biotherapeutics Ab |
A composition comprising anaerobically cultured human intestinal flora
|
|
CA2892588A1
(en)
|
2011-12-01 |
2013-06-06 |
School Corporation, Azabu Veterinary Medicine Educational Institution |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
WO2013121573A1
(ja)
|
2012-02-17 |
2013-08-22 |
住友商事株式会社 |
ソフトバイオマスの分解方法
|
|
WO2013166031A1
(en)
|
2012-04-30 |
2013-11-07 |
The Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
US10130665B2
(en)
|
2012-05-18 |
2018-11-20 |
Genome Research Limited |
Method for identifying bacteria for bacteriotherapy
|
|
US10722577B2
(en)
|
2012-05-25 |
2020-07-28 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
MX2015006491A
(es)
|
2012-11-23 |
2015-12-03 |
Seres Health Inc |
Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
|
|
WO2014088982A1
(en)
|
2012-12-07 |
2014-06-12 |
Albert Einstein College Of Medicine Of Yeshiva University |
Gut barrier dysfunction treatment and prevention
|
|
EP2951283A4
(en)
|
2013-02-04 |
2017-01-25 |
Seres Therapeutics, Inc. |
Compositions and methods
|
|
MX369877B
(es)
|
2013-02-04 |
2019-11-25 |
Seres Therapeutics Inc |
Composiciones y metodos.
|
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
|
JP2016519664A
(ja)
|
2013-03-15 |
2016-07-07 |
セレス セラピューティクス インコーポレイテッド |
ネットワークを基にした微生物組成物及び方法
|
|
US9962415B2
(en)
|
2013-05-03 |
2018-05-08 |
Nestec S.A. |
Lachnospiraceae in the gut microbiota and association with body weight
|
|
WO2015018307A1
(en)
|
2013-08-06 |
2015-02-12 |
Bgi Shenzhen Co., Limited |
Biomarkers for colorectal cancer
|
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
EP3146065B1
(en)
|
2014-05-19 |
2024-11-13 |
Memorial Sloan Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
|
ES3010296T3
(en)
|
2014-11-25 |
2025-04-02 |
Memorial Sloan Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
US20180200308A1
(en)
|
2015-07-08 |
2018-07-19 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
|
JP2018531908A
(ja)
|
2015-09-04 |
2018-11-01 |
メモリアル スローン ケタリング キャンサー センター |
癌の再発のリスクを検出するための方法及び組成物
|
|
WO2017074257A1
(en)
|
2015-10-26 |
2017-05-04 |
Nanyang Technological University |
Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents
|
|
US20190247447A1
(en)
|
2015-11-24 |
2019-08-15 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
EP3379935A4
(en)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
METHOD AND COMPOSITIONS FOR REDUCING VANCOMYCIN RESISTANT ENTEROKOKKEN
|
|
US20180369297A1
(en)
|
2015-12-14 |
2018-12-27 |
Metabogen Ab |
Treatment of intrahepatic cholestasis and related liver diseases
|
|
AU2017234120B2
(en)
|
2016-03-14 |
2024-06-20 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
US11260083B2
(en)
|
2016-03-15 |
2022-03-01 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and preventing graft versus host disease
|
|
WO2017182796A1
(en)
|
2016-04-19 |
2017-10-26 |
Genome Research Limited |
Bacteriotherapy
|
|
KR102658297B1
(ko)
|
2016-06-14 |
2024-04-18 |
베단타 바이오사이언시즈, 인크. |
클로스트리디움 디피실레 감염의 치료
|
|
EP3518946A4
(en)
|
2016-09-27 |
2020-09-09 |
Board of Regents, The University of Texas System |
METHODS TO IMPROVE IMMUNE CHECKPOINT BLOCKING TREATMENT BY MODULATING THE MICROBIOME
|
|
BR112020002992A2
(pt)
|
2017-08-14 |
2020-08-18 |
Seres Therapeutics, Inc. |
composições e métodos para tratamento de doença colestática
|
|
AU2018346255A1
(en)
|
2017-10-03 |
2020-04-23 |
Seres Therapeutics, Inc. |
Manipulation of tryptamine metabolism
|
|
JP2021501185A
(ja)
|
2017-10-30 |
2021-01-14 |
セレス セラピューティクス インコーポレイテッド |
抗生物質耐性を処置するための組成物及び方法
|
|
CA3088782A1
(en)
|
2018-01-23 |
2019-08-01 |
The General Hospital Corporation |
Compositions and methods for improving mitochondrial function
|
|
US20210361721A1
(en)
|
2018-03-28 |
2021-11-25 |
Seres Therapeutics, Inc. |
Treatment of a cancer by microbiome modulation
|
|
JP2021519763A
(ja)
|
2018-03-29 |
2021-08-12 |
セレス セラピューティクス インコーポレイテッド |
炎症性腸疾患を治療するための組成物及び方法
|
|
KR20210024481A
(ko)
|
2018-05-24 |
2021-03-05 |
세레스 테라퓨틱스, 인코포레이티드 |
설계된 박테리아 조성물 및 이의 용도
|
|
EP3890505A4
(en)
|
2018-12-05 |
2022-11-02 |
Seres Therapeutics, Inc. |
COMPOSITIONS FOR STABILIZING BACTERIA AND THEIR USES
|
|
US20230125810A1
(en)
|
2019-11-27 |
2023-04-27 |
Seres Therapeutics, Inc. |
Designed bacterial compositions and uses thereof
|